Apixaban reduced thromboembolism risk in cancer patients

Apixaban reduced thromboembolism risk in cancer patients

"Apixaban for Cancer Patients: Reducing Clots but Increasing Bleeding"Подробнее

'Apixaban for Cancer Patients: Reducing Clots but Increasing Bleeding'

Benefits of apixaban among venous thromboembolism patients with active cancerПодробнее

Benefits of apixaban among venous thromboembolism patients with active cancer

MRCP | Respiratory (Pneumocystis jiroveci) - Test 13 | Dr. Bhatia Videos | DBMCI | eGurukul 2.0Подробнее

MRCP | Respiratory (Pneumocystis jiroveci) - Test 13 | Dr. Bhatia Videos | DBMCI | eGurukul 2.0

DVT and PE. Treatment Options. When & What.Подробнее

DVT and PE. Treatment Options. When & What.

Perioperative Anticoagulant Management: An Update - C ClarkeПодробнее

Perioperative Anticoagulant Management: An Update - C Clarke

ASH12: Extending Apixaban Cut Risk of Venous ThromboembolismПодробнее

ASH12: Extending Apixaban Cut Risk of Venous Thromboembolism

Updates in Anticoagulation 2015 videoПодробнее

Updates in Anticoagulation 2015 video

Grand Rounds: Cancer Thrombosis with Dr. RojanПодробнее

Grand Rounds: Cancer Thrombosis with Dr. Rojan

Antithrombotic Therapy for Atrial Fibrillation: Trials and TribulationsПодробнее

Antithrombotic Therapy for Atrial Fibrillation: Trials and Tribulations